Thursday, September 29th | 5 Tishri 5783

November 16, 2020 12:38 pm

Moderna Covid-19 Vaccine Hailed as Benefit of US-Israel Cooperation

avatar by Algemeiner Staff

Vials with stickers reading ‘COVID-19 / Coronavirus vaccine / Injection only’ and a syringe are seen in front of a displayed Moderna logo, in this illustration taken on Oct. 31, 2020. Photo: Reuters / Dado Ruvic / Illustration / File.

America’s envoy to the Jewish state on Monday hailed US-Israel cooperation after Moderna announced that its experimental Covid-19 vaccine was 94.5% effective in preventing the disease.

Noting that Moderna’s chief medical officer, Tal Zaks, was an Israeli who studied at Ben-Gurion University of the Negev, Ambassador David Friedman tweeted, “Another great example of Israelis and Americans working together to make the world a better place!”

Zaks told BBC News on Monday, “The overall effectiveness has been remarkable… it’s a great day.”

In early June, as reported by The Algemeiner, Zaks credited “the first-rate education” he got at Ben-Gurion University, but noted that the story of how Israel put him on his present course “actually starts from the times I was a medic in the IDF.”

At the time, Zaks predicted Massachusetts-based Moderna would be able to produce “a billion doses” of a Covid-19 vaccine in 2021.

Later in June, Israel signed a deal with Moderna for the future purchase of its vaccine.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.